September 2026

CORONA Remedies Limited is a Fastest Crowing Pharmaceutical Organization based from Ahmedabad, (India). We offer finest working culture to professionals. Our “Caro for Coronets" is Industry Known concept due to which we have good number of Talents joining us. We are proud to say that as on date we are 4000+ Coronets who have gone beyond just growth but turned ourselves into a force to reckon with.

Post: Sr. Officer / Executive - Production, QA, QC

Eugia Pharma is focused on making healthcare more accessible by delivering solutions that truly matter. The company provides sterile products, essential injectables, and life-saving oncology therapies aimed at making a real difference in patients' lives. Its approach is built on three core pillars: superior patient experience, commitment to quality, and value-based care. These pillars guide Eugia Pharma in ensuring that its solutions meet high standards while making a meaningful difference where they are needed most.

Sanofi and Cheplapharm have announced plans to establish a new strategic partnership focused on the management of mature medicines. Under the proposed agreement, Cheplapharm will take over 20 mature medicines and three Sanofi manufacturing sites worldwide, while Sanofi will receive a 26.4% equity stake in Cheplapharm.

The U.S. Food and Drug Administration (FDA) has launched a new Expedited Investigational New Drug (IND) Pilot Program aimed at reducing the time required to move promising drug candidates from development into first-in-human (FIH) clinical trials in the United States.

Under the pilot, drug sponsors will partner with Qualified Research Institutions (QRIs), which can include academic medical centers, contract research organizations, health networks and other research organizations with relevant scientific and regulatory expertise.